NEW YORK – M2Gen said Wednesday that it has received an unspecified new investment from Clayton, Dubilier & Rice, the Merck Global Health Innovation Fund, and McKesson Ventures. M2Gen said that the investment makes private equity firm CD&R its largest shareholder.